扁桃炎(Tonsillitis):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)

◆英語タイトル:Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2015159
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:75以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥660,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[扁桃炎(Tonsillitis):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s, “Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Tonsillitis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Tonsillitis. The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Tonsillitis. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturersacross the globe coveringDrug Master FilingsofUS, Europe and API Manufacturers in Asia specifically China and India. The researchanalysis also presents the global sales forecasts data till 2016.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market therapeutics scenario for Tonsillitis.
• A review of the marketed products under prescription for Tonsillitis, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Tonsillitis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Tonsillitis drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Tonsillitis drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Tonsillitis drugs.
• Coverage of Tonsillitis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016.

*** レポート目次(コンテンツ)***

Table of Contents
Indication Overview
Marketed Drugs
Marketed Details of Drugs by Application Type
Marketed Details of Drugs (NDA) by Marketing Status
Marketed Details of Drugs by Patent Expiration Timeline
Active Pharmaceutical Ingredient (API) Manufacturers Assessment
API Manufacturers by United States Drug Master File (US DMF) Status
API Manufacturers by US DMF Status (Drug Specific)
API Manufacturers in Europe by Country
API Manufacturers in India by State
API Manufacturers in China by Province
Marketed Details of Approved Drugs by Geography
Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
API Manufacturers by US DMF Status (Drug Specific)
Drugs Market Data and Forecasted Sales Figure (2012-2016)
Marketed Drugs for Tonsillitis
Drug Name
Drug Description
Global Active Pharmaceutical Manufacturers for Drug
Approval Status of Drug
Patent and Exclusivity Details for Drug
Company Profile and Financials
Phase III Drugs for Tonsillitis
United States Drug Master File (DMF)
Discontinued Drugs for Tonsillitis
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Tonsillitis Therapeutic Market, US, Marketed Drugs by Application Type, 2015
Tonsillitis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015
Tonsillitis Therapeutic Market, US, (Year), 2015
Tonsillitis Marketed Drugs, API Manufacturers by US DMF Status, 2015
Tonsillitis Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Tonsillitis Drugs, API Manufacturers, Europe by Country, 2015
Tonsillitis Drugs, API Manufacturers, India by State, 2015
Tonsillitis Drugs, API Manufacturers, China by Province, 2015
Tonsillitis Drugs, API Manufacturers by Geography 2015
Tonsillitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2015
Tonsillitis Therapeutic Market, Global Sales 2012-2016 (in million USD)
API Manufacturers for Drug, 2015
Phase III Drugs for Tonsillitis, 2015
Discontinued Drugs for Tonsillitis, 2015


List of Figures
Tonsillitis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015
Tonsillitis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015
Tonsillitis Therapeutic Market, US, (Year), 2015
Tonsillitis Marketed Drugs, API Manufacturers by US DMF Status (%), 2015
Tonsillitis Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Tonsillitis Drugs, API Manufacturers, Europe by Country, 2015
Tonsillitis Drugs, API Manufacturers, India by State, 2015
Tonsillitis Drugs, API Manufacturers, China by Province, 2015
Tonsillitis Drugs, API Manufacturers by Geography 2015
Tonsillitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2015
Tonsillitis Therapeutic Market, Global Sales 2012-2016 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2015


*** レポートのキーワード ***

扁桃炎(Tonsillitis)、医薬品、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2015159 )"扁桃炎(Tonsillitis):治療薬市場動向2015(市場規模、APIメーカー動向、上市品、フェーズ3治験)" (英文:Tonsillitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。